9 research outputs found

    p-BioSPRE-an information and communication technology framework for transnational biomaterial sharing and access

    Get PDF
    Biobanks represent key resources for clinico-genomic research and are needed to pave the way to personalised medicine. To achieve this goal, it is crucial that scientists can securely access and share high-quality biomaterial and related data. Therefore, there is a growing interest in integrating biobanks into larger biomedical information and communication technology (ICT) infrastructures. The European project p-medicine is currently building an innovative ICT infrastructure to meet this need. This platform provides tools and services for conducting research and clinical trials in personalised medicine. In this paper, we describe one of its main components, the biobank access framework p-BioSPRE (p-medicine Biospecimen Search and Project Request Engine). This generic framework enables and simplifies access to existing biobanks, but also to offer own biomaterial collections to research communities, and to manage biobank specimens and related clinical data over the ObTiMA Trial Biomaterial Manager. p-BioSPRE takes into consideration all relevant ethical and legal standards, e.g., safeguarding donors’ personal rights and enabling biobanks to keep control over the donated material and related data. The framework thus enables secure sharing of biomaterial within open and closed research communities, while flexibly integrating related clinical and omics data. Although the development of the framework is mainly driven by user scenarios from the cancer domain, in this case, acute lymphoblastic leukaemia and Wilms tumour, it can be extended to further disease entities.FP7/2007-2013/27008

    BioSim - A New Qualitative Simulation Environment for Molecular Biology

    No full text
    Traditionally, biochemical systems are modelled using kinetics and differential equations in a quantitative simulator. However, for many biological processes detailed quantitative information is not available, only qualitative or fuzzy statements about the nature of interactions. In a previous paper we have shown the applicability of qualitative reasoning methods for molecular biological regulatory processes. Now, we present a newly developed simulation environment, BioSim, that is written in Prolog using constraint logic programming techniques. The simulator combines the basic ideas of two main approaches to qualitative reasoning and integrates the contents of a molecular biology knowledge base, EcoCyc. We show that qualitative reasoning can be combined with automatic transformation of contents of genomic databases into simulation models to give an interactive modelling system that reasons about the relations and interactions of biological entities. This is demonstrated on the glycoly..

    Improving Semi-Quantitative Reasoning by Landmark Approximation

    No full text
    Many extensions to existing qualitative simulation packages allow combined use of available numeric and qualitative information. Some provide numeric integration across two qualitative states but none of them highlights numerically or semi-quantitatively the qualitatively predicted time points. Moreover, high accuracy at time points is only achieved by a fine level of granularity across the entire time interval. This paper presents landmark approximation as a new methodology to improve semi-quantitative predictions in qualitative simulation. We also present a transition table and a method to propagate semi-quantitative values that is suitable for landmark approximation. These techniques have been implemented in a simulation engine that is based on qualitative reasoning techniques with a semi-quantitative extension. We demonstrate that a semi-quantitative approximation to landmarks improves the predictive power of the simulation tool even with a reduced number of inter..

    Applying ILP to Diterpene Structure Elucidation from &sup1³C NMR Spectra

    No full text
    . We present a novel application of ILP to the problem of diterpene structure elucidation from 13 C NMR spectra. Diterpenes are organic compounds of low molecular weight that are based on a skeleton of 20 carbon atoms. They are of significant chemical and commercial interest because of their use as lead compounds in the search for new pharmaceutical effectors. The structure elucidation of diterpenes based on 13 C NMR spectra is usually done manually by human experts with specialized background knowledge on peak patterns and chemical structures. In the process, each of the 20 skeletal atoms is assigned an atom number that corresponds to its proper place in the skeleton and the diterpene is classified into one of the possible skeleton types. We address the problem of learning classification rules from a database of peak patterns for diterpenes with known structure. Recently, propositional learning was successfully applied to learn classification rules from spectra with assigned atom ..

    Safeguarding donors' personal rights and biobank autonomy in biobank networks: the CRIP privacy regime

    Full text link
    Governance, underlying general ICT (Information and Communication Technology) architecture, and workflow of the Central Research Infrastructure for molecular Pathology (CRIP) are discussed as a model enabling biobank networks to form operational "meta biobanks" whilst respecting the donors' privacy, biobank autonomy and confidentiality, and the researchers' needs for appropriate biospecimens and information, as well as confidentiality. Tailored to these needs, CRIP efficiently accelerates and facilitates research with human biospecimens and data

    Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance

    No full text
    Purpose: Post-treatment follow-up in women with cervical pre-cancers (CIN3) is mandatory due to relapse in up to 10% of patients. Standard follow-up based on hrHPV-DNA/cytology co-testing has high sensitivity but limited specificity. The aim of our prospective, multicenter, observational study was to test the hypothesis that an individualized viral-cellular-junction test (vcj-PCR) combined with cytology has a lower false positive rate for the prediction of recurrence compared to standard co-testing. Methods: Pre-surgical cervical swabs served for the identification of HPV16/18 DNA integration sites by next-generation-sequencing (NGS). Samples taken at 6, 12 and 24 months post-surgery were evaluated by cytology, hrHPV-DNA and the patients’ individual HPV-integration sites (vcj-PCR on the basis of NGS). Results: Integration sites were detected in 48 of 445 patients (10.8%), 39 of them had valid follow-up data. The false positive rate was 18.2% (95% CI 8.6–34.4%) for standard hrHPV/cytology at six months compared to 12.1% (95% CI 4.8–27.3%) for vcj-PCR/cytology, respectively (McNemar p = 0.50). Six patients developed recurrences (1 CIN2, 5 CIN3) during follow-up. Standard co-testing detected all, whereas vcj-PCR/cytology detected only five patients with recurrences. Data of 269 patients without evidence of HPV16/18 integration were subject to post-hoc analyses. Standard co-testing revealed a false positive rate of 15.7% (95% CI 11.7–20.7%) and predicted ten of fourteen recurrences at six months. Conclusions: Although highly specific on its own vcj-PCR could not detect all recurrent CIN2/3. Possible reasons for this unexpected result may be multifocal lesions, intratumoral heterogeneity with respect to HPV integration and/or incident CIN
    corecore